Related Experiment Videos

Quantitative analysis of tumor biochemisty using PET and SPECT

W C Eckelman¹, J L Tatum, K A Kurdziel

¹PET Department, National Institutes of Health, Bethesda, MD, USA.

Nuclear Medicine and Biology

|November 25, 2000

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

First-in-human phase 0 study of 111In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Journal of translational science·2019

Utility of 18F-fluoroestradiol (18F-FES) PET/CT imaging as a pharmacodynamic marker in patients with refractory estrogen receptor-positive solid tumors receiving Z-endoxifen therapy.

European journal of nuclear medicine and molecular imaging·2016

Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.

Molecular imaging and biology·2011

Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Molecular psychiatry·2010

A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.

Journal of medicinal chemistry·2008

The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software.

Clinical pharmacology and therapeutics·2008

See all related articles